TIVC · NASDAQ · Medical - Specialties

Tivic Health Systems (TIVC)

Develops TLR5 immunotherapies and biomanufacturing services for radiation and oncology uses.

$0.2577
At close−0.03 (−10.46%)
No recent trading data